6-chloro-1-oxo-4-phenyl-1H-isochromene-3-carboxylic acid | 142256-41-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异香豆素及其衍生物
• 英文名称: 6-chloro-1-oxo-4-phenyl-1H-isochromene-3-carboxylic acid
• 英文别名: 6-chloro-4-phenyl-3-isocoumarincarboxylic acid；6-chloro-1-oxo-4-phenyl-1H-2-benzopyran-3-carboxylic acid；6-chloro-1-oxo-4-phenyl-1H-isochromen-3-carboxylic acid；6-chloro-4-phenylisocoumarin-3-carboxylic acid；6-chloro-1-oxo-4-phenylisochromene-3-carboxylic acid
• CAS: 142256-41-5
• 化学式: C₁₆H₉ClO₄
• 分子量: 300.698
• InChiKey: XUZWTICQEASECI-UHFFFAOYSA-N

物化性质

• 沸点：
  449.5±45.0 °C(Predicted)
• 密度：
  1.492±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-chloro-1-oxo-4-phenyl-1H-isochromene-3-carboxylic acid 在 盐酸 、 叠氮磷酸二苯酯 、 三乙胺 作用下， 以 甲醇 、 乙酸乙酯 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 57.5h， 生成 3-amino-6-chloro-2-methyl-4-phenylisoquinolin-1(2H)-one
  参考文献：
  名称：

  Identification of 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones: A new class of potent, selective, and orally active non-peptide dipeptidyl peptidase IV inhibitors that form a unique interaction with Lys554

  摘要：

  The design, synthesis, and structure-activity relationships of a new class of potent and orally active non-peptide dipeptidyl peptidase IV (DPP-4) inhibitors, 3-aminomethyl-1,2-dihydro-4-phenyl-1-isoquinolones, are described. We hypothesized that the 4-phenyl group of the isoquinolone occupies the S1 pocket of the enzyme, the 3-aminomethyl group forms an electrostatic interaction with the S2 pocket, and the introduction of a hydrogen bond donor onto the 6- or 7-substituent provides interaction with the hydrophilic region of the enzyme. Based on this hypothesis, intensive research focused on developing new non-peptide DPP-4 inhibitors has been carried out. Among the compounds designed in this study, we identified 2-[(3-aminomethyl-2-(2-methylpropyl)-1-oxo-4-phenyl-1,2-dihydro-6-isoquinolinyl) oxy] acetamide (35a) as a potent, selective, and orally bioavailable DPP-4 inhibitor, which exhibited in vivo efficacy in diabetic model rats. Finally, X-ray crystallography of 35a in a complex with the enzyme validated our hypothesized binding mode and identified Lys554 as a new target-binding site available for DPP-4 inhibitors. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.06.059
• 作为产物：
  描述：

  2-苯甲酰基-4-氯苯甲酸 在 potassium carbonate 作用下， 以 DMF (N,N-dimethyl-formamide) 、 丙酮 为溶剂， 反应 40.17h， 生成 6-chloro-1-oxo-4-phenyl-1H-isochromene-3-carboxylic acid
  参考文献：
  名称：

  JNK INHIBITOR

  摘要：

  一种含有异喹啉酮骨架或其盐的JNK抑制剂，例如由以下公式表示的化合物： 其中环A和环B分别是可选择取代的苯环，X是-O-，-N=，-NR3-或-CHR3-，R2是酰基，可选择酯化或硫酯化的羧基，可选择取代的氨基甲酰基或可选择取代的氨基等，虚线表示单键或双键，R1是氢原子，可选择取代的碳氢基团，可选择取代的杂环基团等。

  公开号：

  EP1484320A1

文献信息

• Heterocyclic amine, derivatives, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05198462A1

  公开（公告）日：1993-03-30

  A novel heterocyclic amine derivative of the general formula: ##STR1## wherein a ring A and a ring B stand independently for an optionally substituted benzene ring, Z.degree. stands for O or S or ##STR2## stands for --CH.sub.2 --, X stands for O, S or NR.sup.1 wherein R.sup.1 stands for hydrogen atom or an alkyl group, Y stands for NH, O or (CH.sub.2).sub.n wherein n denotes 0 to 2, and R.sup.2 stands for an optionally substituted hydrocarbon group, or their salts.

  一种新的杂环胺衍生物，其一般式为：##STR1## 其中环A和环B分别独立代表一个可选择取代的苯环，Z°代表O或S或##STR2## 代表--CH2 --，X代表O、S或NR1，其中R1代表氢原子或烷基，Y代表NH、O或(CH2)n，其中n为0至2，R2代表一个可选择取代的碳氢基团，或其盐。
• Condensed heterocyclic compounds, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05482967A1

  公开（公告）日：1996-01-09

  Novel compound represented by the formula: ##STR1## such as 6-Chloro-N-(2,6-diethoxyphenyl)-4-(2-methylphenyl-2-oxo-2H-1-benzopyran-3- acetamide: ##STR2## or a salt thereof. The compound has an excellent activity of inhibiting ACAT, lowering the cholesterol in blood and inhibiting tachykinin receptor. The present invention also relates to the production and use of the disclosed compound.

  代表性化合物如6-氯-N-(2,6-二乙氧基苯基)-4-(2-甲基苯基-2-氧代-2H-1-苯并吡喃-3-基)乙酰胺，其化学式为：##STR1## 或其盐类。该化合物具有优异的抑制ACAT（酰基辅酶A胆固醇酰基转移酶）活性、降低血液胆固醇水平以及抑制速激肽受体的作用。本发明还涉及该化合物的制备方法及其应用。
• 2-Hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic Acid with Inbuilt β-N-Hydroxy-γ-keto-acid Pharmacophore as HCV NS5B Polymerase Inhibitors
  作者：R. R. Deore、G. S. Chen、C. -S. Chen、P. -T. Chang、M. -H. Chuang、T. -R. Chern、H. -C. Wang、J. -W. Chern

  DOI：10.2174/092986712798918833

  日期：2012.2.1

  2-N-hydroxy-1-oxo-3-carboxylic acid of isoquinolone was designed as pyrophosphate mimic for hepatitis C NS5B polymerase. Various 2-hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid derivatives 11a-p were synthesized and evaluated as HCV NS5B polymerase inhibitors. Compound 11c exhibited moderate inhibitory potency based on the inorganic pyrophosphate generation (IC₅₀ = 9.5 μM) and based on NTP incorporation

  异喹诺酮的内置 2-N-羟基-1-氧代-3-羧酸被设计为丙型肝炎 NS5B 聚合酶的焦磷酸盐模拟物。各种 2-羟基-1-氧代-1,2-二氢异喹啉-3-羧酸衍生物 11a-p 被合成并评估为 HCV NS5B 聚合酶抑制剂。化合物 11c 基于无机焦磷酸盐的产生 (IC50 = 9.5 μM) 和基于 NS5B 酶的 NTP 掺入 (IC50 = 5.9 μM) 表现出中等的抑制效力。化合物 11c 在 HCV 基因型 1b 复制子 Ava.5 细胞中显示出抗病毒活性（EC₅0 = 15.7 μM）和良好的选择性。化合物 11c 降低了 NTP 与 NS5B 聚合酶的相互作用。对接模型显示 11c 位于与 NS5B 聚合酶活性位点中结合的三磷酸尿苷相似的方向。结果，2-羟基-1-氧代-1，
• Jnk inhibitor
  申请人：Itoh Fumio

  公开号：US20050148624A1

  公开（公告）日：2005-07-07

  A JNK inhibitor containing a compound having an isoquinolinone skeleton or a salt thereof, such as a compound represented by the formula wherein ring A and ring B are each an optionally substituted benzene ring, X is —O—, —N═, —NR 3 — or —CHR 3 —, R 2 is an acyl group, an optionally esterified or thioesterified carboxyl group, an optionally substituted carbamoyl group or an optionally substituted amino group and the like, a broken line shows a single bond or a double bond, and R 1 is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted heterocyclic group and the like, and the like.

  含有异喹啉酮骨架或其盐的JNK抑制剂，例如由以下式表示的化合物：其中环A和环B均为可选取代的苯环，X为—O—，—N═，—NR3—或—CHR3—，R2为酰基，可选的酯化或硫酯化羧基，可选的取代的氨基甲酰基或可选的取代的氨基基团等，破折号表示单键或双键，而R1为氢原子，可选的取代的碳氢基团，可选的取代的杂环基团等。
• Heterocyclic amine derivatives, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05300646A1

  公开（公告）日：1994-04-05

  A novel heterocyclic amine derivative of the general formula: ##STR1## wherein a ring A and a ring B stand independently for an optionally substituted benzene ring, Z.sup.o stands for O or S or ##STR2## stands for --CH.sub.2 --, X stands for O, S or NR.sup.1 wherein R.sup.1 stands for hydrogen atom or an alkyl group, Y stands for NH, O or (CH.sub.2).sub.n wherein n denotes 0 to 2, and R.sup.2 stands for an optionally substituted hydrocarbon group, or their salts.

  一种新型杂环胺衍生物的一般公式：##STR1## 其中环A和环B独立地代表可选取代的苯环，Z.sup.o代表O或S或##STR2##代表--CH.sub.2 --，X代表O、S或NR.sup.1，其中R.sup.1代表氢原子或烷基，Y代表NH、O或(CH.sub.2).sub.n，其中n表示0~2，R.sup.2代表可选取代的碳氢基团或它们的盐。